Leptin brain entry via a tanycytic LepR-EGFR shuttle controls lipid metabolism and pancreas function.


Journal

Nature metabolism
ISSN: 2522-5812
Titre abrégé: Nat Metab
Pays: Germany
ID NLM: 101736592

Informations de publication

Date de publication:
08 2021
Historique:
received: 12 11 2019
accepted: 23 06 2021
pubmed: 4 8 2021
medline: 5 10 2021
entrez: 3 8 2021
Statut: ppublish

Résumé

Metabolic health depends on the brain's ability to control food intake and nutrient use versus storage, processes that require peripheral signals such as the adipocyte-derived hormone, leptin, to cross brain barriers and mobilize regulatory circuits. We have previously shown that hypothalamic tanycytes shuttle leptin into the brain to reach target neurons. Here, using multiple complementary models, we show that tanycytes express functional leptin receptor (LepR), respond to leptin by triggering Ca

Identifiants

pubmed: 34341568
doi: 10.1038/s42255-021-00432-5
pii: 10.1038/s42255-021-00432-5
pmc: PMC7611554
mid: EMS128607
doi:

Substances chimiques

Leptin 0
Receptors, Leptin 0
ErbB Receptors EC 2.7.10.1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1071-1090

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK123002
Pays : United States
Organisme : European Research Council
ID : 810331
Pays : International

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Références

Swinburn, B. A. et al. The global syndemic of obesity, undernutrition, and climate change: The Lancet Commission Report. Lancet 393, 791–846 (2019).
doi: 10.1016/S0140-6736(18)32822-8
Yoon, K. H. et al. Epidemic obesity and type 2 diabetes in Asia. Lancet 368, 1681–1688 (2006).
pubmed: 17098087 doi: 10.1016/S0140-6736(06)69703-1
Ohn, J. H. et al. 10-year trajectory of beta-cell function and insulin sensitivity in the development of type 2 diabetes: a community-based prospective cohort study. Lancet Diabetes Endocrinol. 4, 27–34 (2016).
pubmed: 26577716 doi: 10.1016/S2213-8587(15)00336-8
Ahima, R. S. & Flier, J. S. Leptin. Annu. Rev. Physiol. 62, 413–437 (2000).
pubmed: 10845097 doi: 10.1146/annurev.physiol.62.1.413
de Luca, C. et al. Complete rescue of obesity, diabetes, and infertility in db/db mice by neuron-specific LEPR-B transgenes. J. Clin. Invest. 115, 3484–3493 (2005).
pubmed: 16284652 pmcid: 1280964 doi: 10.1172/JCI24059
Cohen, P. et al. Selective deletion of leptin receptor in neurons leads to obesity. J. Clin. Invest 108, 1113–1121 (2001).
pubmed: 11602618 pmcid: 209535 doi: 10.1172/JCI200113914
Caron, A., Lee, S., Elmquist, J. K. & Gautron, L. Leptin and brain-adipose crosstalks. Nat. Rev. Neurosci. 19, 153–165 (2018).
pubmed: 29449715 pmcid: 5962962 doi: 10.1038/nrn.2018.7
Pan, W. W. & Myers, M. G. Jr. Leptin and the maintenance of elevated body weight. Nat. Rev. Neurosci. 19, 95–105 (2018).
pubmed: 29321684 doi: 10.1038/nrn.2017.168
Friedman, J. M. Leptin and the endocrine control of energy balance. Nat. Metab. 1, 754–764 (2019).
pubmed: 32694767 doi: 10.1038/s42255-019-0095-y
Kamohara, S., Burcelin, R., Halaas, J. L., Friedman, J. M. & Charron, M. J. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 389, 374–377 (1997).
pubmed: 9311777 doi: 10.1038/38717
Coppari, R. et al. The hypothalamic arcuate nucleus: a key site for mediating leptin’s effects on glucose homeostasis and locomotor activity. Cell Metab. 1, 63–72 (2005).
pubmed: 16054045 doi: 10.1016/j.cmet.2004.12.004
Buettner, C. et al. Critical role of STAT3 in leptin’s metabolic actions. Cell Metab. 4, 49–60 (2006).
pubmed: 16814732 pmcid: 3638026 doi: 10.1016/j.cmet.2006.04.014
Buettner, C. et al. Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms. Nat. Med. 14, 667–675 (2008).
pubmed: 18516053 pmcid: 2671848 doi: 10.1038/nm1775
Prevot, V. et al. The versatile tanycyte: a hypothalamic integrator of reproduction and energy metabolism. Endocr. Rev. 39, 333–368 (2018).
pubmed: 29351662 doi: 10.1210/er.2017-00235
Garcia-Caceres, C. et al. Role of astrocytes, microglia, and tanycytes in brain control of systemic metabolism. Nat. Neurosci. 22, 7–14 (2019).
pubmed: 30531847 doi: 10.1038/s41593-018-0286-y
Banks, W. A. The blood–brain barrier as an endocrine tissue. Nat. Rev. Endocrinol. 15, 444–455 (2019).
pubmed: 31127254 doi: 10.1038/s41574-019-0213-7
Schaeffer, M. et al. Rapid sensing of circulating ghrelin by hypothalamic appetite-modifying neurons. Proc. Natl Acad. Sci. USA 110, 1512–1517 (2013).
pubmed: 23297228 pmcid: 3557016 doi: 10.1073/pnas.1212137110
Ciofi, P. et al. Brain-endocrine interactions: a microvascular route in the mediobasal hypothalamus. Endocrinology 150, 5509–5519 (2009).
pubmed: 19837874 pmcid: 2819742 doi: 10.1210/en.2009-0584
Yulyaningsih, E. et al. Acute lesioning and rapid repair of hypothalamic neurons outside the blood–brain barrier. Cell Rep. 19, 2257–2271 (2017).
pubmed: 28614713 pmcid: 5651178 doi: 10.1016/j.celrep.2017.05.060
Djogo, T. et al. Adult NG2-glia are required for median eminence-mediated leptin sensing and body weight control. Cell Metab. 23, 797–810 (2016).
pubmed: 27166944 doi: 10.1016/j.cmet.2016.04.013
Mullier, A., Bouret, S. G., Prevot, V. & Dehouck, B. Differential distribution of tight junction proteins suggests a role for tanycytes in blood–hypothalamus barrier regulation in the adult mouse brain. J. Comp. Neurol. 518, 943–962 (2010).
pubmed: 20127760 pmcid: 2892518 doi: 10.1002/cne.22273
Langlet, F. et al. Tanycytic VEGF-A boosts blood–hypothalamus barrier plasticity and access of metabolic signals to the arcuate nucleus in response to fasting. Cell Metab. 17, 607–617 (2013).
pubmed: 23562080 pmcid: 3695242 doi: 10.1016/j.cmet.2013.03.004
Balland, E. et al. Hypothalamic tanycytes are an ERK-gated conduit for leptin into the brain. Cell Metab. 19, 293–301 (2014).
pubmed: 24506870 pmcid: 3936883 doi: 10.1016/j.cmet.2013.12.015
Yuan, X., Caron, A., Wu, H. & Gautron, L. Leptin receptor expression in mouse intracranial perivascular cells. Front. Neuroanat. 12, 4 (2018).
pubmed: 29410615 pmcid: 5787097 doi: 10.3389/fnana.2018.00004
Yoo, S., Cha, D., Kim, D. W., Hoang, T. V. & Blackshaw, S. Tanycyte-independent control of hypothalamic leptin signaling. Front. Neurosci. 13, 240 (2019).
pubmed: 30941008 pmcid: 6433882 doi: 10.3389/fnins.2019.00240
Bhaskar, V. et al. An allosteric antibody to the leptin receptor reduces body weight and reverses the diabetic phenotype in the Lep(ob) /Lep(ob) mouse. Obesity (Silver Spring) 24, 1687–1694 (2016).
doi: 10.1002/oby.21539
Jo, Y. H., Chen, Y. J., Chua, S. C. Jr., Talmage, D. A. & Role, L. W. Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit. Neuron 48, 1055–1066 (2005).
pubmed: 16364907 pmcid: 2280039 doi: 10.1016/j.neuron.2005.10.021
Irani, B. G., Le Foll, C., Dunn-Meynell, A. & Levin, B. E. Effects of leptin on rat ventromedial hypothalamic neurons. Endocrinology 149, 5146–5154 (2008).
pubmed: 18556346 pmcid: 2582924 doi: 10.1210/en.2008-0357
Kusumakshi, S. et al. A binary genetic approach to characterize TRPM5 cells in mice. Chem. Senses 40, 413–425 (2015).
pubmed: 25940069 doi: 10.1093/chemse/bjv023
Niv-Spector, L. et al. Identification of the hydrophobic strand in the A–B loop of leptin as major binding site III: implications for large-scale preparation of potent recombinant human and ovine leptin antagonists. Biochem. J. 391, 221–230 (2005).
pubmed: 15952938 pmcid: 1276919 doi: 10.1042/BJ20050457
Muller-Fielitz, H. et al. Tanycytes control the hormonal output of the hypothalamic-pituitary-thyroid axis. Nat. Commun. 8, 484 (2017).
pubmed: 28883467 pmcid: 5589884 doi: 10.1038/s41467-017-00604-6
Frayling, C., Britton, R. & Dale, N. ATP-mediated glucosensing by hypothalamic tanycytes. J. Physiol. 589, 2275–2286 (2011).
pubmed: 21486800 pmcid: 3098703 doi: 10.1113/jphysiol.2010.202051
Auriau, J. et al. Gain of affinity for VEGF165 binding within the VEGFR2/NRP1 cellular complex detected by an HTRF-based binding assay. Biochem. Pharmacol. 158, 45–59 (2018).
pubmed: 30236477 doi: 10.1016/j.bcp.2018.09.014
Vauthier, V. et al. Design and validation of a homogeneous time-resolved fluorescence-based leptin receptor binding assay. Anal. Biochem. 436, 1–9 (2013).
pubmed: 23333588 doi: 10.1016/j.ab.2012.12.013
Langlet, F., Mullier, A., Bouret, S. G., Prevot, V. & Dehouck, B. Tanycyte-like cells form a blood-cerebrospinal fluid barrier in the circumventricular organs of the mouse brain. J. Comp. Neurol. 521, 3389–3405 (2013).
pubmed: 23649873 pmcid: 3973970 doi: 10.1002/cne.23355
Howard, J. K. & Flier, J. S. Attenuation of leptin and insulin signaling by SOCS proteins. Trends Endocrinol. Metab. 17, 365–371 (2006).
pubmed: 17010638 doi: 10.1016/j.tem.2006.09.007
Chmielewski, A. et al. Preclinical assessment of leptin transport into the cerebrospinal fluid in diet-induced obese minipigs. Obesity (Silver Spring) 27, 950–956 (2019).
doi: 10.1002/oby.22465
Balland, E., Chen, W., Tiganis, T. & Cowley, M. A. Persistent leptin signalling in the arcuate nucleus impairs hypothalamic insulin signalling and glucose homeostasis in obese mice. Neuroendocrinology 109, 374–390 (2019).
pubmed: 30995667 doi: 10.1159/000500201
Sukumaran, S., Xue, B., Jusko, W. J., Dubois, D. C. & Almon, R. R. Circadian variations in gene expression in rat abdominal adipose tissue and relationship to physiology. Physiol. Genomics 42A, 141–152 (2010).
pubmed: 20682845 pmcid: 2957797 doi: 10.1152/physiolgenomics.00106.2010
Tschop, M., Smiley, D. L. & Heiman, M. L. Ghrelin induces adiposity in rodents. Nature 407, 908–913 (2000).
pubmed: 11057670 doi: 10.1038/35038090
Schwartz, M. W. et al. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 45, 531–535 (1996).
pubmed: 8603777 doi: 10.2337/diab.45.4.531
Pelleymounter, M. A. et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269, 540–543 (1995).
pubmed: 7624776 doi: 10.1126/science.7624776
Berglund, E. D. et al. Direct leptin action on POMC neurons regulates glucose homeostasis and hepatic insulin sensitivity in mice. J. Clin. Invest. 122, 1000–1009 (2012).
pubmed: 22326958 pmcid: 3287225 doi: 10.1172/JCI59816
Back, S. H. & Kaufman, R. J. Endoplasmic reticulum stress and type 2 diabetes. Annu. Rev. Biochem. 81, 767–793 (2012).
pubmed: 22443930 pmcid: 3684428 doi: 10.1146/annurev-biochem-072909-095555
Sohn, J. W. et al. Melanocortin 4 receptors reciprocally regulate sympathetic and parasympathetic preganglionic neurons. Cell 152, 612–619 (2013).
pubmed: 23374353 pmcid: 3711728 doi: 10.1016/j.cell.2012.12.022
Muzumdar, R. et al. Physiologic effect of leptin on insulin secretion is mediated mainly through central mechanisms. FASEB J. 17, 1130–1132 (2003).
pubmed: 12709405 doi: 10.1096/fj.02-0991fje
Fagerholm, V., Haaparanta, M. & Scheinin, M. Alpha2-adrenoceptor regulation of blood glucose homeostasis. Basic Clin. Pharmacol. Toxicol. 108, 365–370 (2011).
pubmed: 21418144 doi: 10.1111/j.1742-7843.2011.00699.x
Rosengren, A. H. et al. Overexpression of alpha2A-adrenergic receptors contributes to type 2 diabetes. Science 327, 217–220 (2010).
pubmed: 19965390 doi: 10.1126/science.1176827
Wang, P. et al. A leptin-BDNF pathway regulating sympathetic innervation of adipose tissue. Nature 583, 839–844 (2020).
pubmed: 32699414 doi: 10.1038/s41586-020-2527-y
Ahima, R. S. et al. Role of leptin in the neuroendocrine response to fasting. Nature 382, 250–252 (1996).
pubmed: 8717038 doi: 10.1038/382250a0
Zhou, Y. et al. Temporal dynamic reorganization of 3D chromatin architecture in hormone-induced breast cancer and endocrine resistance. Nat. Commun. 10, 1522 (2019).
pubmed: 30944316 pmcid: 6447566 doi: 10.1038/s41467-019-09320-9
Liu, Z. et al. Short-term tamoxifen treatment has long-term effects on metabolism in high-fat diet-fed mice with involvement of Nmnat2 in POMC neurons. FEBS Lett. 592, 3305–3316 (2018).
pubmed: 30192985 doi: 10.1002/1873-3468.13240
Shida, D., Kitayama, J., Mori, K., Watanabe, T. & Nagawa, H. Transactivation of epidermal growth factor receptor is involved in leptin-induced activation of janus-activated kinase 2 and extracellular signal-regulated kinase 1/2 in human gastric cancer cells. Cancer Res. 65, 9159–9163 (2005).
pubmed: 16230373 doi: 10.1158/0008-5472.CAN-05-0598
Prevot, V., Cornea, A., Mungenast, A., Smiley, G. & Ojeda, S. R. Activation of erbB-1 signaling in tanycytes of the median eminence stimulates transforming growth factor beta1 release via prostaglandin E2 production and induces cell plasticity. J. Neurosci. 23, 10622–10632 (2003).
pubmed: 14627647 pmcid: 6740908 doi: 10.1523/JNEUROSCI.23-33-10622.2003
Lomniczi, A., Cornea, A., Costa, M. E. & Ojeda, S. R. Hypothalamic tumor necrosis factor-alpha converting enzyme mediates excitatory amino acid-dependent neuron-to-glia signaling in the neuroendocrine brain. J. Neurosci. 26, 51–62 (2006).
pubmed: 16399672 pmcid: 6674310 doi: 10.1523/JNEUROSCI.2939-05.2006
Balthasar, N. et al. Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis. Neuron 42, 983–991 (2004).
pubmed: 15207242 doi: 10.1016/j.neuron.2004.06.004
van de Wall, E. et al. Collective and individual functions of leptin receptor modulated neurons controlling metabolism and ingestion. Endocrinology 149, 1773–1785 (2008).
pubmed: 18162515 doi: 10.1210/en.2007-1132
Vauthier, V. et al. Endospanin1 affects oppositely body weight regulation and glucose homeostasis by differentially regulating central leptin signaling. Mol. Metab. 6, 159–172 (2017).
pubmed: 28123946 doi: 10.1016/j.molmet.2016.10.009
Obici, S. et al. Central melanocortin receptors regulate insulin action. J. Clin. Invest. 108, 1079–1085 (2001).
pubmed: 11581309 pmcid: 200952 doi: 10.1172/JCI200112954
Fan, W. et al. The central melanocortin system can directly regulate serum insulin levels. Endocrinology 141, 3072–3079 (2000).
pubmed: 10965876 doi: 10.1210/endo.141.9.7665
Rossi, J. et al. Melanocortin-4 receptors expressed by cholinergic neurons regulate energy balance and glucose homeostasis. Cell Metab. 13, 195–204 (2011).
pubmed: 21284986 pmcid: 3033043 doi: 10.1016/j.cmet.2011.01.010
Coppari, R. & Bjorbaek, C. Leptin revisited: its mechanism of action and potential for treating diabetes. Nat. Rev. Drug Discov. 11, 692–708 (2012).
pubmed: 22935803 pmcid: 4019022 doi: 10.1038/nrd3757
Colberg, S. R., Simoneau, J. A., Thaete, F. L. & Kelley, D. E. Skeletal muscle utilization of free fatty acids in women with visceral obesity. J. Clin. Invest. 95, 1846–1853 (1995).
pubmed: 7706491 pmcid: 295723 doi: 10.1172/JCI117864
Beaufrere, B. & Morio, B. Fat and protein redistribution with aging: metabolic considerations. Eur. J. Clin. Nutr. 54, S48–S53 (2000).
pubmed: 11041075 doi: 10.1038/sj.ejcn.1601025
Zamboni, M., Mazzali, G., Fantin, F., Rossi, A. & Di Francesco, V. Sarcopenic obesity: a new category of obesity in the elderly. Nutr. Metab. Cardiovasc. Dis. 18, 388–395 (2008).
pubmed: 18395429 doi: 10.1016/j.numecd.2007.10.002
Parr, E. B., Coffey, V. G. & Hawley, J. A. ‘Sarcobesity’: a metabolic conundrum. Maturitas 74, 109–113 (2013).
pubmed: 23201324 doi: 10.1016/j.maturitas.2012.10.014
Tian, S. & Xu, Y. Association of sarcopenic obesity with the risk of all-cause mortality: a meta-analysis of prospective cohort studies. Geriatr. Gerontol. Int. 16, 155–166 (2016).
pubmed: 26271226 doi: 10.1111/ggi.12579
Okun, J. G. et al. Liver alanine catabolism promotes skeletal muscle atrophy and hyperglycaemia in type 2 diabetes. Nat. Metab. 3, 394–409 (2021).
pubmed: 33758419 doi: 10.1038/s42255-021-00369-9
Prentki, M. & Nolan, C. J. Islet beta cell failure in type 2 diabetes. J. Clin. Invest. 116, 1802–1812 (2006).
pubmed: 16823478 pmcid: 1483155 doi: 10.1172/JCI29103
Steil, G. M. et al. Adaptation of beta-cell mass to substrate oversupply: enhanced function with normal gene expression. Am. J. Physiol. Endocrinol. Metab. 280, E788–E796 (2001).
pubmed: 11287362 doi: 10.1152/ajpendo.2001.280.5.E788
Tuomi, T. et al. The many faces of diabetes: a disease with increasing heterogeneity. Lancet 383, 1084–1094 (2014).
pubmed: 24315621 doi: 10.1016/S0140-6736(13)62219-9
Morimoto, A. et al. Impact of impaired insulin secretion and insulin resistance on the incidence of type 2 diabetes mellitus in a Japanese population: the Saku study. Diabetologia 56, 1671–1679 (2013).
pubmed: 23680915 doi: 10.1007/s00125-013-2932-y
Peitz, M., Pfannkuche, K., Rajewsky, K. & Edenhofer, F. Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: a tool for efficient genetic engineering of mammalian genomes. Proc. Natl Acad. Sci. USA 99, 4489–4494 (2002).
pubmed: 11904364 pmcid: 123675 doi: 10.1073/pnas.032068699
Folgueira, C. et al. Hypothalamic dopamine signaling regulates brown fat thermogenesis. Nat. Metab. 1, 811–829 (2019).
pubmed: 31579887 pmcid: 6774781 doi: 10.1038/s42255-019-0099-7
Quinones, M. et al. Sirt3 in POMC neurons controls energy balance in a sex- and diet-dependent manner. Redox Biol. 41, 101945 (2021).
pubmed: 33744652 pmcid: 8005845 doi: 10.1016/j.redox.2021.101945
Bruss, M. D., Khambatta, C. F., Ruby, M. A., Aggarwal, I. & Hellerstein, M. K. Calorie restriction increases fatty acid synthesis and whole body fat oxidation rates. Am. J. Physiol. Endocrinol. Metab. 298, E108–E116 (2010).
pubmed: 19887594 doi: 10.1152/ajpendo.00524.2009
Imbernon, M. et al. Central melanin-concentrating hormone influences liver and adipose metabolism via specific hypothalamic nuclei and efferent autonomic/JNK1 pathways. Gastroenterology 144, 636–649 (2013).
pubmed: 23142626 doi: 10.1053/j.gastro.2012.10.051
Nogueiras, R. et al. The central melanocortin system directly controls peripheral lipid metabolism. J. Clin. Invest. 117, 3475–3488 (2007).
pubmed: 17885689 pmcid: 1978426 doi: 10.1172/JCI31743
Golde, W. T., Gollobin, P. & Rodriguez, L. L. A rapid, simple, and humane method for submandibular bleeding of mice using a lancet. Lab. Anim. 34, 39–43 (2005).
doi: 10.1038/laban1005-39
Clasadonte, J., Scemes, E., Wang, Z., Boison, D. & Haydon, P. G. Connexin 43-mediated astroglial metabolic networks contribute to the regulation of the sleep–wake cycle. Neuron 95, 1365–1380 (2017).
pubmed: 28867552 pmcid: 5617118 doi: 10.1016/j.neuron.2017.08.022
Bouret, S. G., Bates, S. H., Chen, S., Myers, M. G. & Simerly, R. B. Distinct roles for specific leptin receptor signals in the development of hypothalamic feeding circuits. J. Neurosci. 32, 1244–1252 (2012).
pubmed: 22279209 pmcid: 3567460 doi: 10.1523/JNEUROSCI.2277-11.2012
Annicotte, J. S. et al. The CDK4-pRB-E2F1 pathway controls insulin secretion. Nat. Cell Biol. 11, 1017–1023 (2009).
pubmed: 19597485 pmcid: 2824657 doi: 10.1038/ncb1915
Blanchet, E. et al. E2F transcription factor-1 regulates oxidative metabolism. Nat. Cell Biol. 13, 1146–1152 (2011).
pubmed: 21841792 doi: 10.1038/ncb2309
de Seranno, S. et al. Role of estradiol in the dynamic control of tanycyte plasticity mediated by vascular endothelial cells in the median eminence. Endocrinology 151, 1760–1772 (2010).
pubmed: 20133455 pmcid: 2850227 doi: 10.1210/en.2009-0870
Rabhi, N. et al. Cdkn2a deficiency promotes adipose tissue browning. Mol. Metab. 8, 65–76 (2018).
pubmed: 29237539 doi: 10.1016/j.molmet.2017.11.012
Dhillon, S. S. & Belsham, D. D. Leptin differentially regulates NPY secretion in hypothalamic cell lines through distinct intracellular signal transduction pathways. Regul. Pept. 167, 192–200 (2011).
pubmed: 21262273 doi: 10.1016/j.regpep.2011.01.005
Zabeau, L. et al. Selection of non-competitive leptin antagonists using a random nanobody-based approach. Biochem. J. 441, 425–434 (2012).
pubmed: 21851341 doi: 10.1042/BJ20110438
Student. The probable error of a mean. Biometrika 6, 1–25 (1908).
Fay, D. S. & Gerow, K. A biologist’s guide to statistical thinking and analysis. Wormbook http://www.wormbook.org/chapters/www_statisticalanalysis/statisticalanalysis.html (2013).
Charan, J. & Biswas, T. How to calculate sample size for different study designs in medical research? Indian J. Psychol. Med. 35, 121–126 (2013).
pubmed: 24049221 pmcid: 3775042 doi: 10.4103/0253-7176.116232

Auteurs

Manon Duquenne (M)

Univ. Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience & Cognition, UMR-S1172, EGID, DISTALZ, Lille, France.

Cintia Folgueira (C)

Universidade de Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain.
CIBER Fisiopatología de la Obesidad y Nutrición, Santiago de Compostela, Spain.

Cyril Bourouh (C)

Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, CNRS, U1283-UMR 8199-EGID, Lille, France.

Marion Millet (M)

Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, Strasbourg, France.

Anisia Silva (A)

Institut Cochin, Inserm U1016, CNRS UMR 8104, University Paris Descartes, Sorbonne Paris Cité, Paris, France.

Jérôme Clasadonte (J)

Univ. Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience & Cognition, UMR-S1172, EGID, DISTALZ, Lille, France.

Monica Imbernon (M)

Univ. Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience & Cognition, UMR-S1172, EGID, DISTALZ, Lille, France.

Daniela Fernandois (D)

Univ. Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience & Cognition, UMR-S1172, EGID, DISTALZ, Lille, France.

Ines Martinez-Corral (I)

Univ. Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience & Cognition, UMR-S1172, EGID, DISTALZ, Lille, France.

Soumya Kusumakshi (S)

Experimental Pharmacology, Center for Molecular Signaling, Saarland University School of Medicine, Homburg, Germany.

Emilie Caron (E)

Univ. Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience & Cognition, UMR-S1172, EGID, DISTALZ, Lille, France.

S Rasika (S)

Univ. Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience & Cognition, UMR-S1172, EGID, DISTALZ, Lille, France.

Eleonora Deliglia (E)

Univ. Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience & Cognition, UMR-S1172, EGID, DISTALZ, Lille, France.

Nathalie Jouy (N)

Univ. Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience & Cognition, UMR-S1172, EGID, DISTALZ, Lille, France.
Flow Cytometry Core Facility, BioImaging Center of Lille, Hospital Campus, UMS2014-US41, Lille, France.

Asturo Oishi (A)

Institut Cochin, Inserm U1016, CNRS UMR 8104, University Paris Descartes, Sorbonne Paris Cité, Paris, France.

Massimiliano Mazzone (M)

Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology, VIB, Department of Oncology, Leuven, Belgium.

Eric Trinquet (E)

Cisbio Bioassays, Parc Technologique Marcel Boiteux, Codolet, France.

Jan Tavernier (J)

VIB-UGent Center for Medical Biotechnology, Gent, Belgium.

Young-Bum Kim (YB)

Division of Endocrinology, Diabetes, and Metabolism, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.

Stéphane Ory (S)

Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, Strasbourg, France.

Ralf Jockers (R)

Institut Cochin, Inserm U1016, CNRS UMR 8104, University Paris Descartes, Sorbonne Paris Cité, Paris, France.

Markus Schwaninger (M)

Institute for Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Lübeck, Germany.

Ulrich Boehm (U)

Experimental Pharmacology, Center for Molecular Signaling, Saarland University School of Medicine, Homburg, Germany.

Ruben Nogueiras (R)

Universidade de Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela, Spain.

Jean-Sébastien Annicotte (JS)

Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, CNRS, U1283-UMR 8199-EGID, Lille, France.

Stéphane Gasman (S)

Centre National de la Recherche Scientifique, Université de Strasbourg, Institut des Neurosciences Cellulaires et Intégratives, Strasbourg, France.

Julie Dam (J)

Institut Cochin, Inserm U1016, CNRS UMR 8104, University Paris Descartes, Sorbonne Paris Cité, Paris, France.

Vincent Prévot (V)

Univ. Lille, Inserm, CHU Lille, Laboratory of Development and Plasticity of the Neuroendocrine Brain, Lille Neuroscience & Cognition, UMR-S1172, EGID, DISTALZ, Lille, France. vincent.prevot@inserm.fr.

Articles similaires

Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
1.00
Humans Magnetic Resonance Imaging Brain Infant, Newborn Infant, Premature
Cerebrospinal Fluid Animals Liver Glymphatic System Spinal Cord
alpha-Synuclein Humans Animals Mice Lewy Body Disease

Classifications MeSH